November 29, 2011; 77 (22) Editorials
Parkinson disease, l-dopa, and neuropathy
Did we miss something?
François Tison, Gwendal Le Masson
First published November 2, 2011, DOI: https://doi.org/10.1212/WNL.0b013e31823de107
Parkinson disease, l-dopa, and neuropathy
Did we miss something?
François Tison, Gwendal Le Masson
Neurology Nov 2011, 77 (22) 1938-1939; DOI: 10.1212/WNL.0b013e31823de107
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 77 no. 22 1938-1939
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published November 2, 2011.
Article Versions
- Previous version (November 2, 2011 - 12:40).
- You are viewing the most recent version of this article.
Copyright & Usage:
Copyright © 2011 by AAN Enterprises, Inc.
Author Disclosures
- François Tison, MD, PhD and
- Gwendal Le Masson, MD, PhD
- François Tison, MD, PhD and
- Gwendal Le Masson, MD, PhD
- From Bordeaux University (F.T., G.L.M.), Bordeaux; CHU de Bordeaux (F.T., G.L.M.), Hôpital Haut-Lévèque, Pessac; Institut des Maladies Neurodégénératives (F.T.), CNRS UMR 5293, Bordeaux; and Institut François Magendie (G.L.M.), INSERM 862, Bordeaux, France.
- Address correspondence and reprint requests to Pr. François Tison, Service de Neurologie, CHU de Bordeaux, GH Sud, Hôpital Haut Lévèque, Avenue de Magellan, 33604 Pessac Cedex, France francois.tison{at}chu-bordeaux.fr
Article usage
Cited By...
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
Dr. Robert Pitceathly and Dr. William Macken
► Watch
Related Articles
Alert Me
Recommended articles
-
Articles
Neuropathy in Parkinson diseasePrevalence and determinantsYusuf A. Rajabally, Jean Martey et al.Neurology, November 02, 2011 -
Articles
Association of homocysteine with plasma amyloid β protein in aging and neurodegenerative diseaseM. C. Irizarry, M. E. Gurol, S. Raju et al.Neurology, November 07, 2005 -
Medical Hypothesis
Homocysteine and levodopaShould Parkinson disease patients receive preventative therapy?Ronald B. Postuma, Anthony E. Lang et al.Neurology, September 13, 2004 -
Articles
Vitamin B12 status and rate of brain volume loss in community-dwelling elderlyA. Vogiatzoglou, H. Refsum, C. Johnston et al.Neurology, September 08, 2008